CHEMO‐FREE TRIPLET COMBINATION OF TGR‐1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL. (June 2017)

Record Type:: Journal Article
Title:: CHEMO‐FREE TRIPLET COMBINATION OF TGR‐1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL. (June 2017)
Main Title:: CHEMO‐FREE TRIPLET COMBINATION OF TGR‐1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL.
Authors:: Nastoupil, L.
Lunning, M.A.
Vose, J.M.
Schreeder, M.T.
Siddiqi, T.
Flowers, C.R.
Cohen, J.B.
Burger, J.A.
Wierda, W.G.
O'Brien, S.
Sportelli, P.
Miskin, H.P.
Purdom, M.A.
Weiss, M.S.
Fowler, N.H.
Abstract:
Is Part Of:: Hematological oncology. Volume 35(2017)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 35(2017)Supplement 2
Issue Display:: Volume 35, Issue 2 (2017)
Year:: 2017
Volume:: 35
Issue:: 2
Issue Sort Value:: 2017-0035-0002-0000
Page Start:: 112
Page End:: 113
Publication Date:: 2017-06
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.2437_101 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2817.xml